Back

Targeted suppression of type 1 interferon signaling during RNA delivery enhances vaccine-elicited immunity

Kim, B. J.; Hosn, R. R.; Remba, T. K.; Dye, J.; Mak, H. H.; Jeong, J. Y.; Cornwall-Brady, M.; Abraham, W.; Maiorino, L.; Melo, M. B.; Li, B.; Zhang, Y.; Dong, Y.; Irvine, D. J.

2025-03-10 bioengineering
10.1101/2025.03.09.642244 bioRxiv
Show abstract

RNA vaccines have emerged as a breakthrough technology, and one promising modality employs alphavirus-derived self-replicating RNA (repRNA) to express vaccine antigens. However, both the lipid nanoparticles (LNP) commonly used to deliver RNA and virus-like amplification of repRNAs trigger innate immune recognition, especially via type I interferon (IFN) signaling. To modulate IFN responses during vaccination, we formulated LNPs co-delivering antigen-encoding RNA together with siRNA targeting the interferon-/{beta} receptor-1 (IFNAR1). siRNA-mediated repression of IFNAR1 increased antigen expression from repRNAs by >10-fold, increased immune cell infiltration, and increased antigen presenting cell activation in the injection site and draining lymph nodes. Compared to repRNA alone, siRNA/repRNA co-delivery increased serum antibody titers >10-fold, dramatically augmented antigen-specific germinal center (GC) B cell responses, and primed 4.4-fold more antigen-specific T cells. Ifnar1 silencing by siRNA co-delivery similarly enhanced mRNA vaccines. Thus, siRNA co-delivery is a readily translatable approach to substantially enhance the immunogenicity of RNA vaccines.

Matching journals

The top 5 journals account for 50% of the predicted probability mass.

1
Nature Communications
○ 5641 papers in training set
Top 7%
21.6%
Similar papers in this journal
2
Nature Biomedical Engineering
○ 47 papers in training set
Top 0.1%
11.7%
Similar papers in this journal
3
ACS Nano
● 113 papers in training set
Top 0.2%
7.8%
Similar papers in this journal
4
Science Translational Medicine
● 127 papers in training set
Top 0.2%
6.6%
Similar papers in this journal
5
Nature Nanotechnology
○ 32 papers in training set
Top 0.1%
5.5%
Similar papers in this journal
50% of probability mass above
6
Science Advances
● 1243 papers in training set
Top 5%
5.4%
7
Molecular Therapy
○ 81 papers in training set
Top 0.3%
5.4%
8
Advanced Science
○ 286 papers in training set
Top 2%
4.0%
9
Nature Biotechnology
○ 172 papers in training set
Top 1%
3.5%
10
Proceedings of the National Academy of Sciences
● 2444 papers in training set
Top 19%
2.7%
11
Biomaterials
○ 84 papers in training set
Top 1.0%
1.7%
12
Cell
○ 431 papers in training set
Top 6%
1.7%
13
Advanced Materials
○ 56 papers in training set
Top 0.7%
1.7%
14
npj Vaccines
○ 67 papers in training set
Top 0.6%
1.3%
15
Cell Research
○ 51 papers in training set
Top 0.9%
1.1%
16
eLife
● 5828 papers in training set
Top 60%
1.1%
17
ACS Central Science
● 71 papers in training set
Top 1%
0.9%
18
Nature Materials
○ 28 papers in training set
Top 0.5%
0.8%
19
Molecular Therapy Nucleic Acids
○ 39 papers in training set
Top 0.9%
0.8%
20
Cell Reports
○ 1498 papers in training set
Top 27%
0.8%
21
Nature Methods
○ 385 papers in training set
Top 7%
0.8%
22
iScience
○ 1154 papers in training set
Top 37%
0.8%
23
Nucleic Acids Research
◐ 1281 papers in training set
Top 15%
0.6%
24
Nano Letters
● 71 papers in training set
Top 1%
0.6%

"Similar papers" are the closest papers from that journal in the model's embedding space. They show what the match is built on, but the ranking comes mostly from a classifier over the whole training set, not from these examples alone.